Cancer Risks

Fred Singer's Commentary ("Cancer Risk Analysis: Major Policy Changes on the Way?" 12[21]:8, Oct. 26, 1998) makes a good point. National and international policies with respect to low-level radiation and chemical exposure, premised on the idea that a single gamma ray or chemical molecule can result in a fatal cancer, are in need of basic change. They conflict with both science and common sense. But using ultrasensitive means to detect DNA damage is the wrong approach. This is like trying to pro

Written byTheodore Rockwell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Fred Singer's Commentary ("Cancer Risk Analysis: Major Policy Changes on the Way?" 12[21]:8, Oct. 26, 1998) makes a good point. National and international policies with respect to low-level radiation and chemical exposure, premised on the idea that a single gamma ray or chemical molecule can result in a fatal cancer, are in need of basic change. They conflict with both science and common sense. But using ultrasensitive means to detect DNA damage is the wrong approach. This is like trying to promote public health by assuring that doorknobs and other objects we contact are absolutely germ-free. The public is already obsessed with the idea that tiny, undetectable quantities of toxins in food, water, air, and soil are killing us, despite all evidence to the contrary. Calling on ever-more-sensitive detectors just feeds that paranoia. We survive in a world of germs and other toxins because the body efficiently nullifies their effects.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies